DKCM
TIL icon

Davidson Kempner Capital Management’s Instil Bio TIL Stock Holding History

Davidson Kempner Capital Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-500
Closed -$254K – 619
2021
Q1 		$254K Buy
+500
New +$257K ﹤0.01% 416

Other funds holding TIL

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Davidson Kempner Capital Management's TIL Position: Q2 2021 in Review

Davidson Kempner Capital Management sold out of Instil Bio (TIL) in Q2 2021, closing a stake of 500 shares — an estimated $254K sold.

Davidson Kempner Capital Management first reported a position in TIL in Q1 2021 and held it in 1 quarter. The position peaked at $254K in Q1 2021. 62 funds tracked by Wall St. Rank hold TIL as of Q2 2021.

  • Davidson Kempner Capital Management reported no remaining Instil Bio position as of Q2 2021 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 500 Instil Bio shares in Q2 2021, an estimated $254K.
  • Davidson Kempner Capital Management first reported a position in Instil Bio in Q1 2021 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Instil Bio position peaked at $254K in Q1 2021.
  • 62 funds tracked by Wall St. Rank held Instil Bio as of Q2 2021.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.